These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9691209)

  • 1. Growth hormone treatment in growth hormone-sufficient and -insufficient children with intrauterine growth retardation/Russell-Silver syndrome.
    Azcona C; Albanese A; Bareille P; Stanhope R
    Horm Res; 1998; 50(1):22-7. PubMed ID: 9691209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.
    Coutant R; Carel JC; Letrait M; Bouvattier C; Chatelain P; Coste J; Chaussain JL
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1070-4. PubMed ID: 9543119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Fjellestad-Paulsen A; Czernichow P; Brauner R; Bost M; Colle M; Lebouc JY; Lecornu M; Leheup B; Limal JM; Raux MC; Toublanc JE; Rappaport R
    Acta Paediatr; 1998 May; 87(5):511-7. PubMed ID: 9641731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
    Ranke MB; Lindberg A;
    Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up height after discontinuation of growth hormone treatment in children with intrauterine growth retardation.
    Darendeliler F; Bundak R; Eryilmaz SK; Günöz H; Baş F; Saka N
    J Pediatr Endocrinol Metab; 2002 Jun; 15(6):795-800. PubMed ID: 12099389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation.
    Stanhope R; Ackland F; Hamill G; Clayton J; Jones J; Preece MA
    Acta Paediatr Scand Suppl; 1989; 349():47-52; discussion 53-4. PubMed ID: 2750531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment of children with short stature secondary to intra-uterine growth retardation: effect of 2 years' treatment and 2 years' follow-up.
    Rosilio M; Carel JC; Blazy D; Chaussain JL
    Horm Res; 1997; 48 Suppl 4():23-8. PubMed ID: 9350442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone in the treatment of short stature in young children with intrauterine growth retardation.
    Czernichow P; Fjellestad-Paulsen A
    Horm Res; 1998; 49 Suppl 2():23-7. PubMed ID: 9730668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW).
    Rakover Y; Dietsch S; Ambler GR; Chock C; Thomsett M; Cowell CT
    Eur J Pediatr; 1996 Oct; 155(10):851-7. PubMed ID: 8891553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
    de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
    Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent short stature in children with intrauterine growth retardation: use of growth hormone treatment.
    Albanese A; Stanhope R
    Horm Res; 1997; 48 Suppl 1():63-6. PubMed ID: 9161874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
    Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
    Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.